# FDA Inspection 1239921 - Scranton Equity Exchange - May 21, 2024

Source: https://www.keypedia.com/records/fda_inspections/scranton-equity-exchange/916207f0-d85d-493a-8d6c-f86ab8cbdf7a
Source feed: FDA_Inspections

> FDA Inspection 1239921 for Scranton Equity Exchange on May 21, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239921
- Company Name: Scranton Equity Exchange
- Inspection Date: 2024-05-21
- Product Type: Animal Drugs & Feeds
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 836260 - 2013-06-05](https://www.keypedia.com/records/fda_inspections/scranton-equity-exchange/536121fa-93ca-44e6-8504-95b1eda54f71)
- [FDA Inspection 791637 - 2012-04-24](https://www.keypedia.com/records/fda_inspections/scranton-equity-exchange/a0ed088e-8271-4437-a634-8fb233b57cc6)
- [FDA Inspection 667335 - 2010-05-27](https://www.keypedia.com/records/fda_inspections/scranton-equity-exchange/b80eedd1-b3c3-43f2-b4b4-7d3e753ec3ab)

Company: https://www.keypedia.com/companies/scranton-equity-exchange/7b9c200b-4040-4558-8785-87c7fb713143

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d